Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




CRISPR-Based Diagnostic Test Detects Pathogens in Blood Without Amplification

By LabMedica International staff writers
Posted on 17 Mar 2025

Rapid detection of pathogens is essential for effective disease management, especially in cases of bloodstream infections. More...

Traditional molecular diagnostics often require nucleic acid preamplification, which increases both time and cost. Now, a new technology enables rapid and highly sensitive detection of multi-drug-resistant bacteria and other pathogens, even at low concentrations.

Researchers from the University of Illinois Grainger College of Engineering (Urbana, IL, USA) have developed a CRISPR-based diagnostic test capable of rapidly detecting low levels of pathogen genetic material in blood samples, without the need for nucleic acid amplification. In CRISPR/Cas diagnostic tests, guide RNAs bind to pathogen DNA or RNA, triggering the activation of Cas enzymes that cleave reporter nucleic acids, which fluoresce when cleaved. However, traditional CRISPR-based techniques struggle to detect pathogens at low concentrations without a preamplification step. To address this, the team developed a CRISPR-based test that eliminates the need for amplification by combining two CRISPR/Cas systems into a complex known as CRISPR-Cascade. One part of the system contains a guide RNA specific to the pathogen's nucleic acid, along with a Cas protein. When the Cas protein cleaves specially engineered nucleic acids added to the system, portions of these nucleic acids can bind to and activate a second CRISPR/Cas unit, triggering a positive feedback loop that amplifies the signal, resulting in a high signal-to-noise ratio.

The research, published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS), demonstrated unprecedented sensitivity for pathogen detection. It successfully detected multi-drug-resistant Staphylococcus aureus DNA without prior amplification at concentrations significantly lower than the detection limits of tests using a single Cas enzyme. The test provided a straightforward "yes/no" result for the presence of any one of four common bloodstream pathogens in spiked samples. The findings suggest that this approach could lead to the development of highly sensitive, rapid CRISPR-based diagnostic tests capable of detecting pathogens in minutes, without the need for nucleic acid amplification.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.